INMUNE BIO INC. Retained Earnings
INMUNE BIO INC. (INMB) had Retained Earnings of -$215.72 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$215.72M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$214.44M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$209.04M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$203.77M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$215.72M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$214.44M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$209.04M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$203.77M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | -$197.30M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$172.84M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$163.10M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$153.89M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$141.79M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$132.05M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$121.02M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$112.61M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | -$104.05M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$97.55M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | -$91.01M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$85.18M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$77.46M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$70.62M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$63.72M 10-K · filed 2023-03-02 | |
| 2021-09-30 | -$54.04M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | -$44.59M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | -$37.93M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | -$33.38M 10-K · filed 2022-03-03 | -$33.38M 10-K · filed 2021-03-04 |
| 2020-09-30 | -$30.17M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$25.45M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$23.35M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$21.28M 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$18.96M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$15.89M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$15.50M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$13.60M 10-K · filed 2020-03-11 | |
| 2017-12-31 | -$1.16M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |